We have just sent out a media release confirming the status and timing expectations around our current pre-clinical trials. This update was prompted initially by the delays in obtaining our cold chain testing and BSL-4 trials but I have to say it was really powerful listing out all of the amazing trials that are in motion… Cold Chain with the FDA, Bio Safety Level 4 COVID-19 Clearance, Dose Sparing Adjuvant with Tulane University, Husbandry Animal trials in Canada and Bangladesh and our three Oncology trials using the only human grade solubilized Ivermectin anywhere in the world.
There is so much amazing work going on and I continue to be very proud of the team and our research partners for this incredible progress across multiple lanes of innovation in such tight timelines.
Having just spent Mother’s Day with my wife and children this past Sunday, I am also reminded of the critical value and importance of our work. My wife Shara lost her mother four years ago to small lung carcinoma and the broad mission of MVMD to have more mothers, fathers, daughters, sons, sisters, brothers and friends is painfully present on occasions like this. Shara’s mother died from the exact same cancer that we are evaluating and the personal connection is for sure a lot to emotionally digest.
So many important projects with such broad ranging benefits for human and animal health and we couldn’t be more honoured to drive forward this important work.
You can read the full media release and related trial status on our website at https://www.mountainvalleymd.com.
Thanks for joining us on this journey to reimagine what is possible!
President & CEO, Mountain Valley MD